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Trimeric autotransporter proteins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. A com-
mon feature of most TAAs is the ability to mediate adherence to eukaryotic cells or extracellular matrix (ECM) proteins via a cell
surface-exposed passenger domain. Here we describe the characterization of EhaG, a TAA identified from enterohemorrhagic
Escherichia coli (EHEC) O157:H7. EhaG is a positional orthologue of the recently characterized UpaG TAA from uropathogenic
E. coli (UPEC). Similarly to UpaG, EhaG localized at the bacterial cell surface and promoted cell aggregation, biofilm formation,
and adherence to a range of ECM proteins. However, the two orthologues display differential cellular binding: EhaGmediates
specific adhesion to colorectal epithelial cells while UpaG promotes specific binding to bladder epithelial cells. The EhaG and
UpaG TAAs contain extensive sequence divergence in their respective passenger domains that could account for these differ-
ences. Indeed, sequence analyses of UpaG and EhaG homologues from several E. coli genomes revealed grouping of the proteins
in clades almost exclusively represented by distinct E. coli pathotypes. The expression of EhaG (in EHEC) and UpaG (in UPEC)
was also investigated and shown to be significantly enhanced in an hns isogenic mutant, suggesting that H-NS acts as a negative
regulator of both TAAs. Thus, while the EhaG and UpaG TAAs contain some conserved binding and regulatory features, they
also possess important differences that correlate with the distinct pathogenic lifestyles of EHEC and UPEC.
Trimeric autotransporter adhesins (TAAs) are a subgroupofATproteins that form a stable trimer on the bacterial cell surface
(13). TAAs have been identified in a wide range of Gram-negative
bacteria and, where characterized, are universally associated with
virulence (31). TAAs are defined by the presence of a short 70- to
100-amino-acid C-terminal membrane anchor domain encom-
passing four -sheets that form a trimer to create a full-sized
-barrel pore (50). This pore facilitates the translocation of the
passenger domain to the cell surface (41, 50). This feature of TAAs
is different from conventional AT proteins, which possess a trans-
location domain composed of around 300 amino acids that en-
compass 12 aliphatic -pleated sheets that together form a -bar-
rel pore (4, 36).
The passenger domain of TAAs requires trimerization for sta-
bility and adhesive activity (12). Modeling of TAAs such as YadA
from Yersinia enterocolitica, Hia from Haemophilus influenzae,
and BadA from Bartonella henselae has revealed three distinct re-
gions within the passenger domain: an N-terminal head, a neck,
and a stalk (35, 51, 60). The N-terminal head structure differs
between TAA proteins and is primarily involved in the adhesion
properties of the protein (35, 60). The YadA head structure con-
tains single-stranded, left-handed-helices, the interface of which
is formed by periodically occurring, conserved sequence motifs
(35). Thesemotifs can be found in the predicted head structures of
many TAAs (51).
The head is connected to the stalk by a short, highly conserved
sequence (the neck) which functions as an adapter between the
large globular head and the narrow stalk domain. The neck is
thought to act like a “safety pin,” holding the three monomers
together, partly explaining the stability of trimeric proteins (35).
The stalk domain is repetitive, fibrous, and highly divergent in
length with its primary function being to extend the head domain
away from the surface of the bacterium (31). It can, however,
confer other functional properties such as serum resistance (30,
41). The variable number of repeats in the stalk domain can lead to
major differences in the size of TAAs. For example, BadA is more
than 3,000 amino acids in length (40) while YadA is only 422
amino acids (27). Large TAAs like BadA have intermittent neck
domains throughout the long stalk structure (31). The domain
buildup of TAA proteins has been demonstrated from the crystal
structure of EibD, an immunoglobulin binding TAAprotein from
Escherichia coli (30, 41).
Recently, a TAA from the uropathogenic E. coli (UPEC) strain
CFT073 was identified (UpaG) that mediates adhesion to human
bladder epithelial cells (56). UpaG promotes cell aggregation and
biofilm formation on abiotic surfaces by CFT073 and various
other UPEC strains as well as binding to the extracellular matrix
(ECM) proteins fibronectin and laminin (56). Prevalence studies
indicated that upaG is frequently associated with extraintestinal E.
coli (ExPEC) strains (56). UpaG has also been identified as a po-
tential protective antigen in ExPEC (20).
Enterohemorrhagic Escherichia coli (EHEC) is a pathogenic
subclass of diarrheagenic E. coli (DEC). Here, we identify a TAA
from E. coli O157:H7, EhaG, which is a positional orthologue of
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UpaG but contains significant sequence divergence within the
passenger-encoding domain. Cloning and expression of the ehaG
gene from E. coli EDL933 revealed that the EhaG TAA possesses
different functional properties than those of UpaG. These func-
tional properties correlate with the distinct tissue tropism of
EHEC and UPEC pathogens. While UpaG and EhaG displayed
different functional characteristics, their expression in UPEC and
EHEC is regulated in a common fashion by H-NS.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The following E. coli strains
were used in this study: BL21(DE3) (Stratagene), MG1655, and MS427
(MG1655flu) (39); OS56 (MG1655flu gfp) (49); UPEC strain CFT073
(33); EHEC strain EDL933 (38); and CFT073upaG (56). Cells were rou-
tinely grown at 28°C or 37°C on solid or in liquid lysogeny broth (LB)
medium (6), supplemented with the appropriate antibiotics: kanamycin
(Kan; 100 g/ml), chloramphenicol (Cam; 30 g/ml), and ampicillin
(Amp; 100g/ml). For growth under defined conditions, M63B1 supple-
mented with 0.4% glucose (M63B1Glu) medium was used as indicated
previously (43).
DNA manipulations and genetic techniques. DNA techniques were
performed as previously described (43). Isolation of plasmid DNA was
carried out using the QIAprep Spin Miniprep kit (Qiagen). Restriction
endonucleases were used according to the manufacturer’s specifications
(NewEngland BioLabs). ChromosomalDNApurificationwas done using
the DNeasy blood and tissue kit (Qiagen). Oligonucleotides were pur-
chased from Sigma (Australia or France). All PCRs requiring proofread-
ing were performed with the Expand high-fidelity polymerase system
(Roche) as described by the manufacturer. Amplified products were se-
quenced to ensure fidelity of the PCR. DNA sequencing was performed
using the ABI BigDye v3.1 kit (ABI) by the Australian Equine Genetics
Research Centre, University of Queensland, Brisbane, Australia. Preva-
lence studies for the upaG and ehaG genes used Taq DNA polymerase, as
described by the manufacturer (New England BioLabs), with the primers
144 (5=-AATACCCAGAGCATTACTAACCTG) and 145 (5=-ACCTTGT
AATTTGTAGACCCAA).
Construction of plasmids.The ehaG genewas amplified by PCR from
EHEC strain EDL933 using specific primers designed from the available
genome sequence (130, 5=-CGCGCTCGAGATAATAAGGAACATTAAT
GAACAAAATATTTAAAG, and 131, 5=-CGCGCAAGCTTTTACCACT
GAATACCGGCACCG). The PCR product was digested with XhoI (for-
ward primer) and HindIII/EcoRI (reverse primer) and ligated to XhoI-
HindIII/EcoRI-digested plasmid pBAD/Myc-HisA. The resultant plasmid
(pOMS01) was then digested with EcoRI and ligated with a correspond-
ingly digested kanamycin resistance-encoding gene cassette to give rise to
plasmid pEhaG-kan (pOMS15). Resistance to kanamycin was required to
facilitate transformation of this plasmid into the flu-negative, gfp-positive
E. coli K-12 strain OS56. The upaG gene from UPEC strain CFT073 has
been described previously (56). Both genes were cloned using the same
strategy, with expression of ehaG/upaG under the control of the arabi-
nose-inducible araBAD promoter (25). Neither gene was cloned as a fu-
sion to the 6His-encoding sequence of pBAD/Myc-HisA.
Construction of mutants. In order to mutate the ehaG gene in
EDL933 and create a lacZ reporter transcriptional fusion in CFT073, we
used homologous recombination mediated by -red recombinase and
either a one-step PCR procedure with 50-bp homology arms for recom-
bination or a three-step PCR procedure with 500-bp homology arms for
recombination (8, 15, 16, 53). The primers used to disrupt the ehaG gene
in EDL933 were 843 (5=-ACAGCTAAAGAGTCAACTGG), 844 (5=-CCA
TGAGGCGGCGACGTATCC), 845 (5=-GAAGCAGCTCCAGCCTACA
CTAATGATGCTCGCTATTCCTTG), and 846 (5=-CTAAGGAGGATAT
TCATATGTGATCCATTAAGTTAGTGTGACTAAGG). The mutation
was confirmed using primers 789 (5=-AGGACGCCCGCCATAAACTG)
and 790 (5=-GGTTTAACGGTTGTGGACAAC) and subsequent se-
quencing. A upaG-lacZ reporter transcriptional fusion in CFT073lac
was constructed using the same approach but employing primers upa-
G.lacZzeo.L-5 (CAGCTTCTGCGCTTATATCAAGGAATAGAGAGCAT
CAATAATGACCATGATTACGGATTC) and upaG.lacZzeo.L-3 (CAT-
CAGGCAATGTGGCGTTTACCCATTTGTTAATGGATGATCAG
TCCTGCTCCTCGGCCAC). Mutants were confirmed via PCR and se-
quencing using primers upaG.ext-5 (AGGAATTCATCCTATGAACC)
and upaG.ext-3 (TTATCGTTCGAACTGCTACTGTC). CFT073lac
upaG::lacZ-zeomutants were screened after mutagenesis with the suicide
plasmid pSC189 carrying the kanamycin-resistant Mariner transposon
described previously (9, 14). Sequencing of the transposon in both direc-
tions enabled identification of the site of insertion and, hence, the gene
disrupted. Mutation of the hns gene in EDL933 and CFT073 was per-
formed as previously described (1).
Biofilm assays. Biofilm formation on polystyrene surfaces was moni-
tored by using 96-well microtiter plates (Iwaki) essentially as previously
described (47). Briefly, cells were grown for 18 h in LB (containing 0.2%
arabinose for induction ofAT-encoding genes) at 37°C,washed to remove
unbound cells, and stained with crystal violet. Quantification of bound
cells was performed by addition of acetone-ethanol (20:80) andmeasure-
ment of the dissolved crystal violet at an optical density of 590 nm
(OD590). Flow chamber experiments were performed as previously de-
scribed (28, 46). Briefly, biofilms were allowed to form on glass surfaces in
a multichannel flow system that permitted continuous monitoring of
their structural characteristics. Flow cells were inoculated with standard-
ized cultures with an OD600 of 0.02 pregrown overnight in M9 medium
containing arabinose and kanamycin. Biofilm development was moni-
tored by confocal scanning laser microscopy at 18 h postinoculation. For
analysis of flow cell biofilms, z-stacks were analyzed using the COMSTAT
software program (26).
Binding to ECMcomponents.Bacterial binding to ECMcomponents
was performed in amicrotiter plate enzyme-linked immunosorbent assay
(ELISA) essentially as previously described (56). Microtiter plates (Max-
isorp;Nunc)were coated overnight at 4°Cwith 2g of the following ECM
proteins: collagen (types I to V), fibronectin, fibrinogen, laminin, elastin,
heparan sulfate, human serum album, and bovine serum albumin (BSA)
(Sigma-Aldrich) or the glycoproteinsN-acetyl-D-galactosamine (NaGal),
N-acetyl-D-glucosamine (NaGlu), or N-acetylneuraminic acid (NaNa).
Wells were washed twice with TBS (137 mM NaCl, 10 mM Tris, pH 7.4)
and then blockedwith TBS-2%milk for 1 h. After beingwashedwith TBS,
200l of washed and standardized (OD600 of 0.1) cultures of E. coli strain
MS427pEhaG, MS427pUpaG, or MS427pBAD was added to 12 replicate
wells per ECM component and the plates were incubated at 37°C for 2 h.
After being washed to remove nonadherent bacteria, adherent cells were
fixed with 4% paraformaldehyde (PFA), washed, incubated for 1 h with
anti-E. coli serum (Meridian Life Sciences Inc.; catalogue no. B65001R)
diluted 1:500 in 0.05% TBS-Tween–0.2% skim milk, washed, and incu-
bated for 1 h with a secondary anti-rabbit antibody conjugated with
horseradish peroxidase (diluted 1:1,000) (Sigma-Aldrich; catalogue no.
A6154). After a final wash, adherent bacteria were detected by adding 150
l of 0.3 mg/ml ABTS [2,2=-azino-bis(3-ethylbenzthiazoline-6-sulfonic
acid) (Sigma-Aldrich) in 0.1 M citric acid, pH 4.3, activated with 1 l/ml
30% hydrogen peroxide] and the absorbance was measured at 405 nm.
Epithelial cell binding assays. T24 human bladder carcinoma cells
and colorectal epithelial (Caco-2) cells were purchased from the Ameri-
can Type Culture Collection and cultured according to standard proto-
cols. The adherence of MS427pEhaG and MS427pUpaG to cultured T24
or Caco-2 cells was examined essentially as previously described (7, 56).
Briefly, wells were seeded with 1.5  105 epithelial cells in 24-well tissue
culture plates and incubated at 37°C in 5%CO2 until they were confluent.
Overnight bacterial cultures were diluted and grown to anOD600 of 0.5 in
LB with appropriate antibiotics (and 0.2% arabinose for ehaG/upaG in-
duction). Bacterial cells were washed and added to triplicate epithelial cell
monolayers at amultiplicity of infection of 10. Incubation was carried out
for 1.5 h at 37°C in 5% CO2. After incubation, monolayers were washed
five times with phosphate-buffered saline (PBS) to remove nonadherent
Totsika et al.
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bacteria. The remaining bacteria were then released by eukaryotic cell lysis
with 0.1% Triton X-100. The number of adherent bacteria, as well as the
inoculating dose, was determined by serial dilution and plating on LB
agar. All experiments were performed in triplicate.
Coinfection of Caco-2 epithelial cell monolayers with fluorescently
tagged MS427pEhaG and MS427pUpaG was carried out essentially as
described above, but with the following modifications. Seeding of epithe-
lial cells was performed in 4-chamber glass culture slides (BDFalcon). The
two bacterial strains were mixed at a 1:1 ratio and incubated with the
Caco-2 cell monolayers for 1.5 h at 37°C in 5% CO2. Following incuba-
tion,monolayerswerewashedfive timeswith PBS to remove nonadherent
bacteria and the adherent bacteria were fixed with 4% paraformaldehyde
(PFA). The PFA was then removed by washing with PBS, and adherent
bacteria were visualized using fluorescence microscopy. Adherent bacte-
ria were counted from 40 fields of view. In these experiments, the levels of
EhaG and UpaG protein produced by MS427pEhaG and MS427pUpaG,
respectively, were similar (data not shown).
Purification of 6His-tagged EhaG=, antibody production, and im-
munoblotting. A 480-bp segment from the passenger-encoding domain of
ehaGwas amplified by PCRwith primers 1707 (5=-TACTTCCAATCCAAT
GCAAACGCTATTGCGATAGGTGCTG) and 1708 (5=-TTATCCACTT
CCAATGTTAAAGCTGTGAACCATTAATGG) from E. coli EDL933
genomic DNA; underlined nucleotides represent the ligation-indepen-
dent cloning (LIC) overhangs used for insertion into plasmid pMCSG7
via LIC (17). The resultant plasmid (pEhaGTruncated) contained bp 652
to 1132 of ehaG fused to a 6His-encoding sequence. E. coli BL21 was
transformed with plasmid pEhaGTruncated and induced with isopropyl-
-D-thiogalactopyranoside (IPTG), and the resultant 6His-tagged
EhaG truncated protein (containing amino acids 218 to 378 of EhaG) was
assessed by SDS-PAGE analysis as previously described (54). Polyclonal
anti-EhaG serum was raised in rabbits by the Institute of Medical and
Veterinary Sciences (South Australia). A polyclonal antiserum raised
against UpaG has been described previously (56). For immunoblotting,
whole-cell lysates were subjected to SDS-PAGE using NuPAGE Novex 3
to 8% Tris-acetate precast gels with NuPAGE Tris-acetate running buffer
and subsequently transferred to polyvinylidene difluoride (PVDF)micro-
porous membrane filters using the iBlot dry blotting system as described
by the manufacturer (Invitrogen). EhaG or UpaG rabbit polyclonal anti-
serum was used as primary antibody, and the secondary antibody was
alkaline phosphatase-conjugated anti-rabbit IgG. Sigma Fast 5-bromo-4-
chloro-3-indolylphosphate–nitroblue tetrazolium (BCIP-NBT) was used
as the substrate in the detection process.
-Galactosidase assays. -Galactosidase assays were performed es-
sentially as previously described (32). Briefly, strains carrying lacZ fusions
were grown on LB plates for 16 h and then inoculated into M63B1Glu
minimal medium. After 16 to 18 h of growth, the culture was diluted in
Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 50 mM -mercapto-
ethanol, 10mMKCl, 1 mMMgSO4, pH 7)–0.004% SDS, chloroformwas
added, and the samples were vortexed to permeabilize the cells. Samples
were incubated at 28°C, and the reaction was initiated by the addition of
o-nitrophenyl--D-galactopyranoside (ONPG). Reactions were stopped
with the addition of sodium bicarbonate, and the enzymatic activity was
assayed in quadruplicate for each strain by measuring the absorbance at
420 nm.Where required,-galactosidase activity was also observed on LB
agar plates containing 5-bromo-4-chloro-3-indolyl--D-galactoside (X-
Gal).
DNA curvature prediction and electrophoretic mobility shift as-
says. The upaG promoter region was analyzed in silico using Bendit, a
program that enables the prediction of a curvature-propensity plot calcu-
lated with DNase I-based parameters (http://hydra.icgeb.trieste.it/dna/)
(57). The curvature is calculated as a vector sum of dinucleotide geome-
tries (roll, tilt, and twist angles) and expressed as degrees per helical turn
(10.5°/helical turn 1°/bp). Experimentally tested curvedmotifs produce
curvature values of 5 to 25°/helical turn, whereas straight motifs give val-
ues below 5°/helical turn. The 250-bp upaG promoter region was ampli-
fied using primers upaG-250-5 (TTAGCAAAATGGCAGCAATT) and
upaG1-3 (TATTGATGCTCTCTATTCCT), and its intrinsic curvature
was assessed by comparing its electrophoretic mobility with that of an
unbentmarker fragment (Promega 100-bpDNA ladder) on an 0.5%Tris-
buffered EDTA (TBE)–7.5% PAGE gel at 4°C for retarded gel electropho-
retic mobility.
Gel shift assays were performed essentially as previously described (5).
A DNA mixture comprising the PCR-amplified upaG promoter region
and TaqI-SspI-digested pBR322 at an equimolar ratio was incubated at
room temperature for 15 min with increasing amounts of native purified
H-NS protein (a gift from S. Rimsky) in 30 l of reaction mixture con-
taining 40 mM HEPES, pH 8, 60 mM potassium glutamate, 8 mM mag-
nesium aspartate, 5mMdithiothreitol, 10% glycerol, 0.1%octylphenoxy-
polyethoxyethanol, and 0.1 mg/ml BSA (H-NS binding buffer). DNA
fragments and DNA-protein complexes were resolved by gel electropho-
resis (0.5% TBE, 3% molecular screening agarose gel run at 50 V at 4°C)
and visualized after staining with ethidium bromide.
RESULTS
Sequence variation in E. coliUpaG homologues correlates with
strain pathotype.We used the translated amino acid sequence of
upaG to probe all protein sequences encoded in 28 E. coli genomes
available in the NCBI database (see Table S1 in the supplemental
material). An intact gene encoding a putative TAAwas found in 24
of the 28 genomes at the same genomic location as that of upaG in
CFT073. Interestingly, three of the E. coli strains lacking the gene
were commensal strains (ATCC 8739, K-12 MG1655, and
W3110). Enteropathogenic E. coli (EPEC) strain E2348/69 con-
tains a truncated gene due to a frameshift mutation. Multiple
alignment of the 24 putative TAA protein sequences revealed that
the signal sequence and translocation domain are highly con-
served, while the passenger domain is highly variable in sequence
and size (Fig. 1A). Phylogenetic analysis of the 24 translated full-
length protein sequences revealed grouping according to strain
pathotype, with sequences from DEC strains clading separately
from those encoded in ExPEC strains (Fig. 1B). Proteins belong-
ing to DEC strains shared high sequence identity (95%), while
proteins encoded in ExPEC genomes shared 53% sequence iden-
tity, significantly higher than the overall 38% identity shared
among the 24 E. coli TAA proteins examined.
upaG is highly prevalent amongdiarrheagenicE. coli strains.
We have previously demonstrated that upaG is commonly found
in UPEC isolates (56). However, the primers used in our previous
molecular screening were designed to amplify sequence from the
passenger domain of upaG that is not conserved among the gene
homologues found in the genome of DEC strains. In order to
determine the prevalence of upaG homologues in DEC strains, we
designed a new set of primers specific to a highly conserved region
within the translocation domain and screened a collection of
Shiga toxin-producing E. coli (STEC) isolates. We also screened a
collection of UPEC isolates with the new set of primers. A product
of the correct size was found in 92% (51/55) of STEC strains and
86.5% (64/74) of UPEC strains, indicating that upaG homologues
are highly prevalent among pathogenic E. coli strains of intestinal
as well as extraintestinal origin.
Comparative sequence analysis ofUpaGandEhaG frompro-
totypic strains UPEC CFT073 and EHEC EDL933, respectively.
We hypothesized that the pathotype-specific grouping of UpaG
homologues, due to the variable sequence of the function-encod-
ing passenger domain, suggests that TAA proteins may have
evolved specificity for their host environment. To test this tenet,
EhaG and UpaG TAAs of E. coli
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we selected one representative protein from the ExPEC group and
one from the DEC clade to perform a detailed comparative se-
quence and functional analysis. UpaG from the prototypic UPEC
strain CFT073 was chosen as the only functionally characterized
TAA member from E. coli and was compared to its positional
orthologue in the prototypic EHEC strain EDL933 (gene z5029).
The z5029 gene was named ehaG, in a fashion consistent with
previously characterized AT proteins from EHEC (58) while still
acknowledging that it is a positional orthologue of upaG from
UPEC. The ehaG gene (4,767 bp) encodes a protein similar to
UpaG, containing an extended N-terminal signal sequence with
predicted cleavage after amino acid 53, as well as an 89-amino-
acid C-terminal translocation domain conserved among all TAA
adhesins (Fig. 2A). Despite being positional orthologues, upaG
and ehaG differ significantly in size and sequence (Fig. 2A). The
predicted proteins are 1,778 and 1,588 amino acids, respectively,
with the difference due to the presence of 190 additional amino
acids in the passenger domain of UpaG (Fig. 2A). In fact, although
their translocation domains are 100% identical, the two proteins
share only 65% identity over the passenger domain. Sequence
FIG 1 Sequence analysis of UpaG homologues from 24 E. coli genomes available on the NCBI database and listed in Table S1 in the supplemental material. (A)
Similarity plot of 24 UpaG translated amino acid sequences aligned using Clustal W. High sequence conservation (indicated by shading on the y axis) was
observed in the signal peptide (red) and translocator domain (yellow), while diversity in sequence and size was seen in the passenger domain (blue) of the
proteins. (B) Unrooted phylogram of 24 UpaG translated amino acid sequences. Branch confidence levels are90% and were determined from 1,000 bootstrap
replicates of neighbor-joining trees calculated using PHYLIP (22). Taxon identifications represent the locus tags assigned to upaG orthologues in each E. coli
genome sequence (see Table S1). Sequences from commensal and laboratory E. coli strains are indicated in blue, sequences from diarrheagenic E. coli (DEC) are
indicated in red, and sequences from extraintestinal pathogenic E. coli (ExPEC) are indicated in green.
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analysis of the passenger domain of EhaG and UpaG against the
Pfam and TIGRFAM databases showed that the proteins contain
13 and 14 Hep_Hag repeats, respectively. The majority of these
28-amino-acid-long repeats are found sequentially at the N-ter-
minal end of the passenger domain (Fig. 2A). The head crystal
structures of TAAs YadA and BadA are composed of such do-
mains (35, 51), and it is likely that this region encodes the head of
the EhaG and UpaG proteins (Fig. 2A). This is also supported by
domain annotation forUpaG and EhaGproteins performed using
the daTAA server (51) (data not shown). EhaG and UpaG also
encompass 12 and 15 HIM motifs, respectively, dispersed along
the passenger domain. This highly conserved 24-amino-acid mo-
tif is known to form the neck structure in YadA (35), a transition
region between the globular head and the narrower stalk domain
of the protein. Alignment of the multiple Hep_Hag and HIM se-
quences present in EhaG and UpaG (Fig. 2B) revealed that HIM
sequences are well conserved between the two homologues,
whereas the Hep_Hag sequences displayed some degree of vari-
ability (Fig. 2B and C).
EhaG from EHEC EDL933 mediates autoaggregation and
biofilm formation. The significant sequence differences in the
passenger domains of EhaG andUpaG prompted us to investigate
whether EhaG possesses the same functional properties as does
UpaG. For this purpose, the ehaG gene was amplified from the
chromosome of EDL933 and cloned into pBAD/Myc-HisA under
the control of the inducible araBAD promoter (25). The pEhaG
vector was introduced into the previously described E. coli flu
mutant strain MS427 (39), which is deficient in Ag43 expression
and thus lacks the ability to autoaggregate and form a biofilm.
Overexpression of EhaG in this background resulted in cell-cell
aggregation from standing overnight cultures within 20 min, in
contrast to the MS427pBAD control (Fig. 3A). We also tested the
ability of EhaG to mediate biofilm formation in two distinct sys-
tems. In the polystyrene microtiter plate assay, MS427pEhaG
formed a significant biofilm compared to the MS427pBAD con-
trol following induction with arabinose (P  0.001; Fig. 3B). To
compare the biofilm-forming capacities of EhaG and UpaG, we
used the dynamic model of a continuous-flow chamber. Green
fluorescent protein (GFP)-tagged MS427 cells (OS56) expressing
ehaG from plasmid pEhaG or upaG from plasmid pUpaG were
monitored for biofilm formation over 18 h using confocal laser
scanning microscopy. In contrast to the OS56pBAD control, cells
producing either EhaG or UpaG formed a strong biofilm across
the entire surface of the chamber to a depth of approximately 15
m (Fig. 3C).
EhaG andUpaG bind to ECMproteins.A common feature of
TAAs is the ability to mediate binding to components of the ECM
such as collagen and laminin.We therefore examined the ability of
EhaG and UpaG to bind to a range of ECM proteins. The
MS427pEhaG and MS427pUpaG strains both displayed binding
to laminin, fibronectin, fibrinogen, and collagen types I, II, III,
and V (Fig. 4). In contrast, no UpaG/EhaG-mediated binding was
observed to type IV collagen, elastin, heparan sulfate, human se-
rum albumin, bovine serum albumin, or the glycans N-acetyl-D-
galactosamine (NaGal),N-acetyl-D-glucosamine (NaGlu), andN-
acetylneuraminic acid (NaNa) (Fig. 4 and data not shown). Thus,
EhaG and UpaG mediate binding to selected ECM proteins, and
FIG 2 In silico analysis of UpaG and EhaG homologues. (A) Schematic illustration of the domain organization of UpaG and EhaG proteins. Indicated are the
signal peptide (S.P.), translocator domain (Pfam: YadA), and the localization of the multiple invasin (Pfam: Hep_Hag) and hemagglutinin (Pfam: HIM)motifs
within the passenger domain. (B) Multiple sequence alignment of the Hep_Hag repeats and HIM motifs of EhaG and UpaG. The domains were identified by
sequence searches against the Pfam (23) and TIGRFAM databases hosted by the Comprehensive Microbial Resource (http://cmr.jcvi.org). Highly conserved
residues are indicated in red. (C) Consensus sequence of the EhaG and UpaG Hep_Hag repeats and HIM motifs. Dots, no consensus; lowercase letters, some
consensus; uppercase letters, high consensus.
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the binding specificity to these ECM proteins is conserved be-
tween the two TAAs.
EhaG and UpaG mediate differential cellular adhesion. All
TAAs characterized to date play a role in adhesion. We have pre-
viously demonstrated that UpaG enhances adhesion of CFT073 to
T24 bladder epithelial cells (56).We therefore investigated if EhaG
has a similar function; however, no increase was observed in the
number of adherent bacteria recovered from T24 bladder epithe-
lial cell monolayers infected with EhaG-producing MS427 cells
compared to cells infected with MS427pBAD (Fig. 5A). Since
EhaG is encoded by an enteric pathogen, we therefore tested its
ability to mediate binding to intestinal epithelial cells. The num-
ber of adherent bacteria recovered after incubation of Caco-2 ep-
ithelial cell monolayers with MS427pEhaG was significantly
higher than after incubation with the MS427pBAD control (Fig.
5A). The ability of EhaG to mediate bacterial adhesion to intesti-
nal epithelial cells prompted us to investigate if UpaG can also
mediate adhesion to Caco-2 cells. MS427pUpaG failed to adhere
to Caco-2 epithelial cell monolayers at significantly higher
numbers than did theMS427pBAD control (Fig. 5A). Upon coin-
fection of Caco-2 epithelial cell monolayers with a mixed (1:1)
population of EhaG- and UpaG-producing MS427 cells that
carried different fluorescent chromosomal markers (green for
MS427pEhaG and red for MS427pUpaG), EhaG-producing cells
adhered at 2.5-fold-greater numbers than did UpaG-producing
cells (Fig. 5B and C). Reverse competition experiments using red
MS427pEhaG and green MS427pUpaG cells produced a similar
result (data not shown), ruling out a potential fluorophore-de-
pendent bias in bacterial numbers.
Regulation of upaG expression by H-NS. We did not detect
expression of UpaG or EhaG in protein samples prepared from in
FIG 3 EhaG promotes autoaggregation and biofilm formation in E. coli. (A) Settling profile of liquid suspensions of E. coli strainsMS427pBAD (vector control)
and MS427pEhaG. Suspensions were prepared from overnight LB cultures supplemented with 0.2% arabinose normalized at an OD600 of 1. Bacterial autoag-
gregation is inversely proportional to the optical density of each suspensionmeasured at 600 nm over a period of 60 min. (B) Biofilm formation by E. coli strains
MS427pBAD (vector control) and MS427pEhaG following 18 h of culture in LB medium supplemented with 0.2% arabinose. Biofilm formation was examined
in polystyrene 96-wellmicrotiter plates using crystal violet staining. Bar charts show average absorbancemeasurements at 590 nm standard errors of themeans
from three independent experiments. (C) Fluorescent micrographs of continuous-flow biofilms formed in glass chambers 18 h after inoculation with GFP-
labeled E. coli strains (I) OS56pBAD (vector control), (II) OS56pEhaG, and (III) OS56pUpaG. Micrographs show representative horizontal sections collected
within each biofilm. Shown to the right and top of each individual panel are vertical sections representing the yz plane and the xz plane, respectively, at the
positions indicated by the red and green lines.
FIG 4 EhaG and UpaG mediate E. coli adherence to ECM proteins. ELISA-
based assay demonstrating binding of E. coliMS427pEhaG (black bars), E. coli
MS427pUpaG (gray bars), and E. coliMS427pBAD (white bars) to collagen (I
to V), fibronectin, fibrinogen, and BSA. Results represent average absorbance
readings at 405 nm  standard errors of the means from three independent
experiments. The expression of EhaG and UpaG was induced with 0.2% ara-
binose.
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vitro-cultured UPEC CFT073 and EHEC EDL933, respectively,
using Western blotting with specific polyclonal antiserum (data
not shown) (56). To explore possible reasons for this lack of ex-
pression, we constructed a lacZ reporter fusion to the chromo-
somal promoter of upaG in CFT073 (CFT073lac_upaG::lacZ)
and subjected the strain to randomMariner transposonmutagen-
esis in order to identify negative regulators of upaG expression.
Screening of 20,000mutants identified twomutants with-galac-
tosidase activity. Both mutants carried transposon insertions in
different positions of the gene encoding the global regulatorH-NS
(corresponding to amino acid positions 97 and 127 of the H-NS
protein). To confirm the regulatory role of H-NS in expression of
upaG, we constructed an hns deletion in CFT073lac_upaG::lacZ
and subsequently complemented this strain with a plasmid con-
taining the hns gene downstream of the inducible araBAD pro-
moter. Relative -galactosidase activity was measured in
M63B1Glu-grown cultures of CFT073lac_upaG::lacZ_hns
complemented with empty pBAD30 vector or pBAD30hns in the
absence or presence of 0.2% arabinose. Deletion of hns in CFT073
derepressed upaG expression by 6-fold, which was reversed upon
complementation with pBAD30hns but not the pBAD30 control
under arabinose induction (Fig. 6A).
H-NS binds to the upaG promoter region.H-NS has an affin-
ity for AT-rich, intrinsically curved double-stranded DNA. The
250-bp promoter region of upaG is 60.4% AT rich, and we exam-
ined its properties as well as its H-NS binding capacity using
several approaches. First, we generated an in silico curvature-pro-
pensity plot calculated with DNase I-based parameters and
showed that this 250-bp segment may adopt a curved conforma-
tion (Fig. 6B). Next, we demonstrated this curvature experimen-
tally by examination of the PCR-amplified 250-bp fragment using
polyacrylamide gel electrophoresis at 4°C. Using this method,
which has been used previously to demonstrate DNA curvature
(55, 59), the 250-bp upaG promoter region displayed a slightly
retarded gel electrophoretic mobility compared to that of non-
curved DNA standards (Fig. 6C). Finally, to demonstrate direct
binding of H-NS to the 250-bp promoter region of upaG, we per-
formed electrophoretic mobility shift assays. The 250-bp PCR
product wasmixed with TaqI-SspI-digested pBR322DNA (which
contains the bla promoter and has been previously shown to be
bound by H-NS), incubated with increasing concentrations of
purifiedH-NS protein, and subsequently visualized by gel electro-
phoresis. The 250-bp upaG promoter region and the fragment
containing the bla promoter were retarded in mobility by the ad-
dition of 0.5 M H-NS (Fig. 6D). The pBR322 fragments not
containing the bla promoter were not influenced byH-NS at these
concentrations, indicating thatH-NS binds with specificity. These
results suggest that H-NS binds to the regulatory region of upaG
by recognizing a DNA region within 250 bp 5= of the ATG trans-
lation start codon.
Mutation of the hns gene results in increased expression of
upaG and ehaG.To confirm thatH-NS acts as a repressor of upaG
expression, we constructed an hns isogenicmutant in CFT073 and
examined UpaG production by Western blot analysis. Loss of
FIG 5 EhaG mediates E. coli adhesion to intestinal epithelial cells. (A) Efficiency of binding of E. coli MS427 containing pBAD, pEhaG, or pUpaG to T24 and
Caco-2 epithelial cell monolayers. Bars represent the average numbers of adherent bacteria (CFU) per epithelial cell monolayer standard errors of the means.
(B) Competitive adhesion to Caco-2 epithelial cell monolayers of mixed (1:1) bacterial inocula containing MS427green-pEhaG and MS427red-pUpaG. Bars
represent average numbers of each bacterial strain (CFU) per field of view standard errors of the means. (C) Representative field of view of micrographs used
to quantify the number of UpaG- and EhaG-producing adherent bacteria in the competitive Caco-2 epithelial cell adhesion assay. MS427pEhaG cells are tagged
with GFP, and MS427pUpaG cells are tagged with red fluorescent protein. The expression of EhaG and UpaG was induced with 0.2% arabinose.
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FIG 6 H-NS repression of upaG expression in UPEC CFT073. (A) -Galactosidase activity of a chromosomal upaG::lacZ reporter fusion in CFT073lac and
CFT073lac_hns alone, with pBAD30 (vector control) or pBAD30hns (complementation vector). pBAD30- and pBAD30hns-containing strains were grown in
the presence of 0.2% arabinose. (B) Curvature plot of the upaG promoter sequence. (C) Electrophoretic mobility of the upaG promoter sequence. (D)
Electrophoretic mobility shift assay of H-NS binding to the upaG and bla promoter sequences.
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H-NS in CFT073 resulted in an increase in the production of
UpaG that was detectable by Western blot analysis using an anti-
UpaG specific serum (Fig. 7A). We also constructed an isogenic
EDL933 hns mutant strain and tested for EhaG expression by
Western blot analysis using an anti-EhaG specific serum. Similarly
to CFT073, deletion of hns in EDL933 resulted in increased ex-
pression of the EhaG protein (Fig. 7B). Taken together, these re-
sults demonstrate thatH-NSnegatively regulates the expression of
upaG in CFT073 and ehaG in EDL933.
DISCUSSION
TAAs are an important group of virulence factors in many Gram-
negative pathogens. TAAs are translocated to the cell surface via
the type V secretion pathway and adopt a trimeric conformation
in the outermembrane. Three TAAs have been characterized from
pathogenic E. coli, namely, UpaG, Saa, and the Eib group of pro-
teins (37, 44, 56). Here we have characterized the EhaG protein, a
TAA from enterohemorrhagic E. coliO157:H7. Like its positional
orthologueUpaG fromUPEC, EhaGmediates bacterial cell aggre-
gation, biofilm formation, and adherence to ECMproteins. How-
ever, in contrast to UpaG (which mediates specific adherence to
bladder epithelial cells), EhaG mediates specific adherence to in-
testinal epithelial cells.
EhaG andUpaGboth possess a classical TAAdomain structure
consisting of an N-terminal signal sequence, a passenger domain,
and a C-terminal translocation domain. The translocation do-
main is themost conserved feature of the TAA family, with the 70-
to 100-amino-acid C-terminal region responsible for transloca-
tion of the passenger domain to the bacterial surface in all TAAs
(41). We showed previously that the last 71 amino acids of UpaG,
corresponding to the L1- subdomain, represent the transloca-
tion unit (56). This region is completely conserved at the amino
acid level in EhaG and UpaG.
In contrast to the translocation domain, the passenger domain
of EhaG and UpaG exhibits extensive amino acid sequence vari-
ability (65% identity). Further analysis of the passenger domain
revealed that the Hep_Hag motifs in the predicted head region
were more variable than the HIM motifs in the stalk and neck
structures. The head region has been found to be responsible for
adhesion in other TAAs (31). Although the structural domains
responsible for the binding properties of EhaG andUpaGhave not
been defined, it is likely that sequence differences in the head re-
gion account for the different EhaG and UpaG cell adherence
phenotypes observed in this study.
Most trimeric AT proteins characterized to date display an ad-
hesive activity mediating bacterial interactions with either host
cells or ECMproteins (3, 10, 11, 24, 42, 45). Both EhaG andUpaG
possessed several conserved features—theymediated cell aggrega-
tion; biofilm formation; and adhesion to laminin, fibronectin, fi-
brinogen, and collagen types I, II, III, and V. There are several
features of both proteins that could account for these observa-
tions. The multiple Hep_Hag motifs in the head region, despite a
degree of sequence variation, could mediate some of these func-
tions. Alternatively, these properties may be associated with con-
served structural features of both proteins rather than the pres-
ence of specific binding domains.
We found that the sequence divergence in the passenger do-
main of EhaG and UpaG corresponded strongly with diarrhea-
genic and extraintestinal E. coli pathotypes. In the case of DEC
strains, EhaG is highly conserved and exhibits95% amino acid
identity. In contrast, the sequence of UpaG among ExPEC strains
was more variable. The UpaG protein from UPEC CFT073 has
previously been shown to mediate cell aggregation, biofilm for-
mation, and adhesion to the ECM proteins laminin and fibronec-
tin (56). The extensive sequence variation of UpaG suggests that
there may be differences in these functional properties between
UpaG variants from different UPEC/ExPEC strains. Thus, a more
detailed analysis of the functions of different UpaG variants is
required to properly assess its role in virulence.
Adherence of EHEC to the intestinal epithelium is essential for
initiation of infection. The adherence ofE. coliO157:H7 toCaco-2
cells has been shown to proceed in two stages: an initial diffuse
adherence to epithelial cells followed by proliferation to develop
microcolonies and intimate adherence (52). The intimate attach-
ment andmicrocolony formation are thought to bemediated pri-
marily by intimin-Tir interactions whereas the diffuse adherence
to Caco-2 cells requires multiple factors encoded by the locus of
enterocyte effacement (LEE) and additional chromosomal loci
(52). Some of the proteins implicated in this initial adherence
include ToxB and EspA (21, 52). The diffuse pattern of adherence
mediated by EhaG to Caco-2 cells following expression in E. coli
K-12 suggests that it may contribute to initial adherence of E. coli
O157:H7 to intestinal epithelial cells. This remains to be demon-
strated.
Immunodetection employing antibodies specific to EhaG and
UpaG failed to detect these proteins in whole-cell extracts pre-
pared from wild-type strains EDL933 and CFT073, respectively.
We were also unable to detect expression of EhaG or UpaG from
wild-type bacteria during interaction with cultured epithelial cells
(data not shown). This prompted us to examine possible mecha-
nisms by which the expression of ehaG and upaG could be re-
pressed.We initially focused our analysis on upaG and identified a
role for H-NS in its regulation. At the transcriptional level, a sig-
nificant increase in upaG promoter activity was observed in a
CFT073lac_upaG::lacZ-zeo hnsmutant. Consistent with this re-
sult, we also observed an increase in the expression of the UpaG
protein by CFT073 in an hns mutant background. H-NS is a his-
tone-like DNA binding protein that shows affinity for A-T-rich
and bent nucleation sites on DNA (18, 19). Our data demonstrate
that H-NS acts as a repressor of upaG transcription, most likely
through direct binding to a region comprising the 250 bp up-
streamof the upaG open reading frame. This sequence shares 83%
nucleotide sequence conservation with the corresponding region
in ehaG; indeed, we also observed an increase in the expression of
EhaG by EDL933 in an hns mutant background. Thus, the tran-
FIG 7 Production of UpaG (in CFT073) and EhaG (in EDL933) in an hns
mutant background.Western blot analysis of whole-cell lysates prepared from
E. coli CFT073 and CFT073hns employing a rabbit polyclonal anti-UpaG se-
rum (A) and from E. coli EDL933 and EDL933hns using a rabbit polyclonal
anti-EhaG serum (B). ThemonomericUpaG and EhaGproteins are indicated;
possible oligomeric forms of each protein are indicated by asterisks.
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scription of ehaG and upaG is negatively regulated by H-NS. It is
possible that the transcription of ehaG (in EHEC) and upaG (in
UPEC) is coordinated with those of other H-NS-repressed genes.
For example, mutation of the hns gene in UPEC strain 536 results
in the derepression of multiple virulence factors, including alpha-
hemolysin, iron uptake systems, and fimbriae (34), and several
cryptic E. coli chaperone-usher fimbrial genes have also been
shown to be repressed by H-NS in E. coli (29). The binding of
H-NS to DNA is also modulated by temperature, with relief of
repression for many genes observed above a threshold tempera-
ture of 32°C (19). Although we did not observe expression of
EhaG/UpaG at 37°C in our experiments, it is possible that these
proteins are expressed under specific conditions such as those
during host infection.
In this study, we have examined the functional properties of
the trimeric autotransporter EhaG from EHEC and compared its
characteristics to UpaG from UPEC. Both proteins share several
conserved features and yet also possess unique properties thatmay
be associated with host tissue tropism and pathogenesis. Their
common regulation by the global regulator H-NS suggests that
their expression might be coordinated with other virulence fac-
tors, but the temporal and spatial patterns of UpaG and EhaG
expression during disease remain to be elucidated. One property
common to EhaG and UpaG is the ability to mediate biofilm for-
mation. The role of biofilm formation in chronic bladder infec-
tion by UPEC (2) and environmental contamination of food by
EHEC (48) has been documented. Indeed, given the recent out-
break of the STECO104 strain in Germany, it will be important to
thoroughly characterize the role of proteins such as EhaG in bio-
film growth by pathogenic E. coli.
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